Cargando…

Is gemcitabine (GEM)-based combination therapy good for the treatment of advanced pancreatic cancer?

Detalles Bibliográficos
Autores principales:	Hao, Fulong, Chen, Xinyang, Li, Hancong, Feng, Qingbo, Hou, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007943/ https://www.ncbi.nlm.nih.gov/pubmed/36915424 http://dx.doi.org/10.21037/jgo-22-1090

Ejemplares similares

More details are needed about the use of multicenter propensity score matching analysis
por: Feng, Qingbo, et al.
Publicado: (2023)

The clinical efficacy and safety of 3D vascular reconstruction combined with 3D navigation in laparoscopic hepatectomy
por: Li, Hancong, et al.
Publicado: (2023)

Is neutrophil-to-lymphocyte ratio and C-reactive protein the prognostic role in metastatic colorectal cancer using regorafenib?
por: Chen, Xinyang, et al.
Publicado: (2023)

Are sleep duration, sleep apnea, and shift work associated with colorectal cancer risk?
por: Chen, Xinyang, et al.
Publicado: (2023)

Discussion on gemcitabine combined with targeted drugs in the treatment of pancreatic cancer
por: Huang, Jun-Hao, et al.
Publicado: (2023)

Pulmonary surfactant combined with budesonide in the treatment of neonatal respiratory distress syndrome
por: Guo, Hongxing, et al.
Publicado: (2023)

Improved tumor control with antiangiogenic therapy after treatment with gemcitabine and nab‐paclitaxel in pancreatic cancer
por: Zhang, Zheng, et al.
Publicado: (2021)

Endoscopic and laparoscopic resections for gastric stromal tumors which one is better?
por: Huo, Chenyu, et al.
Publicado: (2023)

WWOX rs11644322 Polymorphism, Gemcitabine, and Pancreatic Cancer
por: Yasri, Sora, et al.
Publicado: (2017)

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity
por: Fraunhoffer, Nicolas Alejandro, et al.
Publicado: (2022)

Pulmonary toxicity in patients treated with gemcitabine and a combination of gemcitabine and a taxane: investigation of a signal using postmarketing data
por: Czarnecki, A, et al.
Publicado: (2006)

Real-World Evidence on Palliative Gemcitabine and Oxaliplatin (GemOx) Combination Chemotherapy in Advanced Biliary Tract Cancer
por: Lagenfelt, Hanna, et al.
Publicado: (2021)

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Li, Doudou, et al.
Publicado: (2015)

Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer
por: Min, Young Joo, et al.
Publicado: (2002)

Case report: Adrenal myelolipoma resected by laparoscopic surgery
por: Feng, Qingbo, et al.
Publicado: (2022)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019)

Successful salvage therapy for refractory primary cutaneous gamma-delta T-cell lymphoma with a combination of brentuximab vedotin and gemcitabine
por: Voruz, Sophie, et al.
Publicado: (2021)

Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
por: Habib, Saffiya, et al.
Publicado: (2021)

Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice
por: Panebianco, Concetta, et al.
Publicado: (2021)

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
por: Lim, Jae Yun, et al.
Publicado: (2015)

Is D2 laparoscopic gastrectomy essential for elderly patients with advanced gastric cancer?
por: Feng, Qingbo, et al.
Publicado: (2022)

A case of recurrent malignant fibrous histiocytoma with marked response to combined chemotherapy with gemcitabine and carboplatin
por: Wei, Zhang, et al.
Publicado: (2014)

The efficacy and safety of gemcitabine-based combination therapy vs. gemcitabine alone for the treatment of advanced pancreatic cancer: a systematic review and meta-analysis
por: Zhang, Zhaohuan, et al.
Publicado: (2022)

Comment on: ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
por: Vivaldi, Caterina, et al.
Publicado: (2016)

Gemcitabine-Induced Renal Thrombotic Microangiopathy
por: Chaudhary, Ankur, et al.
Publicado: (2023)

Pegylated G-CSF Combined with mFOLFIRINOX for Advanced Pancreatic Cancer Patients
por: Chen, Peng, et al.
Publicado: (2019)

Reply to the comment on ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort'
por: Pernot, Simon, et al.
Publicado: (2016)

Cost effectiveness of concurrent gemcitabine and cisplatin and radiation followed by adjuvant gemcitabine and cisplatin in stages IIB–IVA cervical cancer
por: Rajan, Narayan, et al.
Publicado: (2014)

Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
por: Li, Ji, et al.
Publicado: (2013)

Case report: A mesocolic lymphangioma in a 14-year-old child resected by laparoscopic surgery
por: Feng, Xuping, et al.
Publicado: (2022)

Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparison
por: Sultana, Asma, et al.
Publicado: (2008)

Good efficacy achieved by telitacicept, corticosteroids and immunosuppressants in the treatment of SLE combined with MOG-AD
por: Tian, Mengxue, et al.
Publicado: (2023)

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma
por: Gong, Dao-Jun, et al.
Publicado: (2013)

A multicentre randomised phase II trial of gemcitabine alone vs gemcitabine and S-1 combination therapy in advanced pancreatic cancer: GEMSAP study
por: Nakai, Y, et al.
Publicado: (2012)

H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer
por: Sorin, Vladimir, et al.
Publicado: (2012)

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
por: Jiménez-Fonseca, P., et al.
Publicado: (2014)

Answer to letter: dissociating advances in orthopaedic trauma management from the climbing patient expectations. “Good vs. good”—setting reasonable goals for patients’ satisfaction
por: Keppler, Lena, et al.
Publicado: (2021)

Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer
por: Okusaka, T, et al.
Publicado: (2004)

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
por: Middleton, Gary, et al.
Publicado: (2016)

Clinical and Immune Effects of Lenalidomide in Combination with Gemcitabine in Patients with Advanced Pancreatic Cancer
por: Ullenhag, Gustav J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vlqq84f7pp0197698b200omulk